СЛИВКОВСКИ Марк Кс. (US),КОРН Вольфганг Майкл (US)
申请号：
RU2015138576
公开号：
RU2015138576A
申请日:
2014.03.14
申请国别(地区):
RU
年份:
2017
代理人:
摘要：
The invention provides combinations comprising a MEK inhibitor (such as GDC-0973 or GDC-0623), or a pharmaceutically acceptable salt thereof and a HER3/EGFR inhibitor (such as MEHD7945A). The combinations are particularly useful for treating hyperproliferative disorders, such as cancer.
